MyBlood ApS: Financial statements 2022
CVR: 41668393
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
MyBlood ApS (CVR 41668393) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -25,000 and a net result of DKK -25,213. Equity in the 2022 report amounted to DKK 2,590. The solvency ratio was 100%.
- Gross Profit
- DKK -25,000
- Profit/Loss
- DKK -25,213
- Equity
- DKK 2,590
- Total Assets
- DKK 2,590
Official annual report
Keep an eye on MyBlood ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
MyBlood ApS has published its interim report for the period September 11, 2020 to December 31, 2021.
About MyBlood ApS
MyBlood ApS is a Danish company of the type Anpartsselskab based in Vodskov, founded in 2020. The company is registered under the industry Fremstilling af instrumenter og udstyr til måling, afprøvning og navigation. The management consists of Christine Maria Røntved. The company is owned by Christine Maria Røntved and Auste Augustyte. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 2,590.